StrongRoom AI Raises $17 Million in Funding
StrongRoom AI, a Melbourne, Australia-based provider of software solutions focused on medication management and care processes for the pharmaceutical industry, has raised $17 million in funding.
The round was led by the EVP Opportunities Fund, with support from existing investors Artesian Venture Partners and InterValley Ventures.
The EVP Opportunities Fund is a growth-stage venture capital fund launched in 2024 by EVP (formerly Equity Venture Partners). It focuses on providing flexible funding to established software businesses in Australia and New Zealand, particularly those seeking capital or liquidity.
The company will use the funding to support its domestic and international expansion and product innovation. Additionally, the company is acquiring the healthcare loyalty program Member Benefits Australia.
Founded in 2017, StrongRoom AI provides medication management, patient engagement, and analytics software to streamline medication tracking, dosage management, and patient adherence. StrongRoom AI combines automation, advanced analytics, and customizable modules to improve administrative efficiency and patient outcomes. It serves over 1,500 customers in Australia and the UK, including major pharmacy groups, and has recently expanded into the US through a partnership with Centennial Management Group.
Funding Details
Company: StrongRoom AI
Raised: $17.0M
Round: Unknown
Funding Date: March 2025
Lead Investor: EVP Opportunities Fund
Additional Investors: Artesian Venture Partners, InterValley Ventures
Company Website: https://strongroom.ai/
Software Category: Healthcare